Bharat Biotech has reduced the prices of its COVID-19 vaccine COVAXIN for state-run hospitals from Rs 600 to Rs 400 per dose. The cost of the COVID-19 vaccine for private hospitals is changed to Rs 1200 per dose.
In what Adar Poonawalla called a “philanthropic gesture”, the Serum Institute of India cut the prices of COVISHIELD from Rs 400 to Rs 300.
Some political activist and leaders have demanded universal free vaccination. However, the company only recently asked for thousands of crores from the Centre to manufacture the vaccines.
The company run by Krishna M Ella said in a statement that Bharat Biotech was deeply concerned with critical pandemic circumstances that India is facing right now. Recognising the state government’s challenges right now, they have made the COVAXIN available to the state governments at Rs 400 per dose. The state government and private hospitals can order up to 50 per cent of COVISHIELD and COVAXIN to inoculate the younger population.
The Centre will continue to vaccinate those above 45 years of age free of cost. Serum Institute had said that it will continue to provide vaccine to the Centre at Rs 150 a shot. Some 1.33 crore people registered for the COVID-19 vaccination in the age group 18 to 44 on Wednesday as government dedicated website cowin.gov.in opened for registrations.
Meanwhile, the University of Delhi in a statement said, “The university is concerned with the health and of our
students which are our priority, We would ensure that the interest of the University Community is protected.
The University has been receiving request related to the examination of terminal semesters / final year
students, scheduled for May-June 2001. The university would take the stock of the situation and would come out with its decision as early as possible. Students are requeto sted fall prey to any • rumours and exclusively follow the notices and (www.du.ac.in)”.